Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | CES2 | O00748 | 4/20 | 0.50 |
| ▸ | CES1 | P23141 | 4/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.50 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.46 |
| ▸ | PPARG | P37231 | 6/20 | 0.46 |
| ▸ | PPARD | Q03181 | 6/20 | 0.46 |
| ▸ | PPARA | Q07869 | 6/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.46 |
| ▸ | TSHR | P16473 | 4/20 | 0.46 |
| ▸ | TLR2 | O60603 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | FABP4 | P15090 | 2/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.46 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.46 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2058928 | 0.98 | ALDH1A1 (0.54) | ALDH1A1CES2CES1EPHX2GPR84 | |
| SCHEMBL2058434 | 0.98 | ALDH1A1 (0.54) | ALDH1A1CES2CES1EPHX2GPR84 | |
| SCHEMBL17914173 | 0.98 | ALDH1A1 (0.54) | ALDH1A1CES2CES1EPHX2GPR84 | |
| SCHEMBL2058987 | 0.98 | ALDH1A1 (0.54) | ALDH1A1CES2CES1EPHX2GPR84 | |
| SCHEMBL2058893 | 0.98 | ALDH1A1 (0.54) | ALDH1A1CES2CES1EPHX2GPR84 | |
| SCHEMBL2058827 | 0.98 | ALDH1A1 (0.54) | ALDH1A1CES2CES1EPHX2GPR84 | |
| SCHEMBL28177818 | 0.98 | ALDH1A1 (0.54) | ALDH1A1CES2CES1EPHX2GPR84 | |
| Water SCHEMBL28491651 | 0.96 | ALDH1A1 (0.52) | ALDH1A1CES2CES1EPHX2GPR84 | |
| SCHEMBL8046344 | 0.93 | ALDH1A1 (0.65) | ALDH1A1CES2CES1EPHX2AKR1B1 | |
| SCHEMBL11782469 | 0.90 | LMNA (0.50) | ALDH1A1CES2CES1EPHX2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114761637-B | Non-rewet O/W (oil-in-water) emulsifying system for hydrophobic compounds | 有机点击股份公司 | 2025-02-11 | — | — | CN | disclosed |
| WO-2024129788-A1 | SMALL MOLECULE INHIBITORS OF THE LINE-1 ENDONUCLEASE DOMAIN | BROWN UNIVERSITY (US) | 2024-06-20 | — | — | WO | disclosed |
| US-20230052708-A1 | NON-REWETTING O/W (OIL IN WATER) EMULSIFICATION SYSTEM FOR HYDROPHOBIC COMPOUNDS | ORGANOCLICK AB (SE) | 2023-02-16 | — | — | US | disclosed |
| EP-4073315-A1 | NON-REWETTING O/W (OIL IN WATER) EMULSIFICATION SYSTEM FOR HYDROPHOBIC COMPOUNDS | OrganoClick AB (SE) | 2022-10-19 | — | — | EP | disclosed |
| CN-114761637-A | Non-rewetting O/W (oil in water) emulsification systems for hydrophobic compounds | 有机点击股份公司 | 2022-07-15 | — | — | CN | disclosed |
| WO-2021118451-A1 | NON-REWETTING O/W (OIL IN WATER) EMULSIFICATION SYSTEM FOR HYDROPHOBIC COMPOUNDS | ORGANOCLICK AB (SE) | 2021-06-17 | — | — | WO | disclosed |
| US-20170174654-A1 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS, INC. | 2017-06-22 | — | — | US | disclosed |
| EP-1694748-B1 | METHOD OF MODIFYING A FLUOROPOLYMERIC SUBSTRATE AND COMPOSITE ARTICLES THEREBY | 3M INNOVATIVE PROPERTIES CO (US) | 2008-04-23 | — | — | EP | disclosed |
| US-7273531-B2 | Method of modifying a fluoropolymeric substrate and composite articles thereby | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2007-09-25 | — | — | US | disclosed |
| EP-1694748-A1 | METHOD OF MODIFYING A FLUOROPOLYMERIC SUBSTRATE AND COMPOSITE ARTICLES THEREBY | 3M Innovative Properties Company (US) | 2006-08-30 | — | — | EP | disclosed |
| US-6967196-B1 | Sulfonamide compounds and uses thereof | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-11-22 | — | — | US | disclosed |
| WO-2005047373-A1 | METHOD OF MODIFYING A FLUOROPOLYMERIC SUBSTRATE AND COMPOSITE ARTICLES THEREBY | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-05-26 | — | — | WO | disclosed |
| US-20050092429-A1 | Method of modifying a fluoropolymeric substrate and composite articles thereby | 3M INNOVATIVE PROPERTIES COMPANY | 2005-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170174654-A1 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | HBG2, HBG1, HBB | ALDH1A1 1089/4885CES2 3611/4885CES1 2795/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.